Articles

Utility of positron emission tomography-computed tomography in patients with chronic lymphocytic leukemia following B-cell receptor pathway inhibitor therapy

CLL Program, Leukemia Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
University of Texas MD Anderson Cancer Center, Houston, TX
Dana-Farber Cancer Institute, Boston, MA
Georgetown University Hospital, Washington, DC
Stanford Cancer Center, Stanford University School of Medicine, Stanford, CA
UCSD Moores Cancer Center, San Diego, CA
Weill Cornell Medicine, New York, NY
Emory University School of Medicine, Atlanta, GA
Wilmot Cancer Institute, University of Rochester Medical Center, Rochester, NY
University of California Los Angeles, Los Angeles, CA
AbbVie Inc. North Chicago, IL
AbbVie Inc. North Chicago, IL
AbbVie Inc. North Chicago, IL
AbbVie Inc. North Chicago, IL
AbbVie Inc. North Chicago, IL
The Ohio State University, Columbus, OH, USA
Vol. 104 No. 11 (2019): November, 2019 https://doi.org/10.3324/haematol.2018.207068